Interleukin 24
Interleukin 24[edit]
Interleukin 24 (IL-24) is a cytokine that belongs to the interleukin family, which plays a crucial role in the immune system. It is part of the larger IL-10 cytokine family and is known for its ability to induce apoptosis in various cancer cells while sparing normal cells.
Structure and Function[edit]
IL-24 is a protein encoded by the IL24 gene in humans. It is characterized by its unique ability to selectively target cancer cells, making it a potential therapeutic agent in oncology. The cytokine functions by binding to specific receptors on the surface of target cells, initiating a cascade of intracellular signals that lead to cell death.
Mechanism of Action[edit]
The mechanism by which IL-24 induces apoptosis involves the activation of the JAK-STAT signaling pathway, which is crucial for transmitting information from extracellular chemical signals to the cell nucleus, resulting in gene expression changes. IL-24 also interacts with the endoplasmic reticulum stress pathways, further promoting apoptosis in cancer cells.
Clinical Implications[edit]
IL-24 has been studied for its potential use in gene therapy for cancer treatment. Its ability to selectively induce apoptosis in cancer cells without affecting normal cells makes it an attractive candidate for therapeutic development. Clinical trials are ongoing to evaluate the efficacy and safety of IL-24-based therapies in various types of cancer.
Related Cytokines[edit]
IL-24 is closely related to other cytokines in the IL-10 family, such as IL-19, IL-20, and IL-22. These cytokines share structural similarities and often have overlapping functions in immune regulation and inflammation.
Research and Development[edit]
Ongoing research is focused on understanding the detailed molecular mechanisms of IL-24 and its interactions with other cellular pathways. Scientists are also exploring the potential of IL-24 in combination with other cancer therapies to enhance its efficacy and overcome resistance.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
